Media Publications - Critical Path Institute

November 14, 2024

C-Path’s Initiative to Optimize Clinical Trial Design in New-Onset Type 1 Diabetes

In honor of World Diabetes Day and the need to improve diabetes treatment, Critical Path Institute’s Type 1 Diabetes Consortium

November 13, 2024

C-Path expands its worldwide leadership in accelerating drug development in neurology; seeks additional collaborators to broaden..

November 7, 2024

Dr. Diane Stephenson Promoted to Vice President of Neurology; Dr. Nadine Tatton Welcomed as New Executive Director of CPAD.

April 9, 2025-April 10, 2025

On April 9-10, 2025, the 2025 Clinical Outcome Assessment...

November 6, 2024

When C-Path launched its new website, it was built to be sleek, mobile, responsive and navigable.

October 29, 2024

Join us Tuesday, October 29, at noon Eastern for an important webinar, New Findings on Inequities in Rare Diseases...

October 16, 2024

October is ADHD Awareness Month, dedicated to raising awareness about Attention Deficit Hyperactivity Disorder (ADHD) and

October 16, 2024

Critical Path Institute (C-Path) is pleased to announce the expansion of our partnership with the Coordination...

November 5, 2024

Paul Belmonte, C-Path’s Scientific Director, T1D Consortium, and Luke Kosinski, Director, Quantitative Medicine, will present...

September 30, 2024

Type 1 diabetes (T1D) is an autoimmune disease characterized by the destruction...